secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2026-02-27T23:59:59+00:00
Accession:  0001104659-26-021654
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio enters $100M at-the-market equity agreement with Jefferies, terminates prior ATM
--------------------------------------------------------------------------------

- Entered Open Market Sale Agreement (ATM) with Jefferies LLC for up to $100M of common stock.
- Jefferies will receive up to 3.0% commission on gross proceeds from sales.
- Terminated prior ATM agreement with Chardan Capital Markets and Craig-Hallum that allowed up to $7.35M.
- Sales under new ATM to be made via Nasdaq or in privately negotiated transactions, subject to conditions.
- Shelf registration statement filed Feb 27, 2026; no assurance of effectiveness.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000110465926021654/0001104659-26-021654-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000110465926021654/tm267467d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-021654

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer